01/14/2025
3:47 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:38 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 424B3 | |
12/26/2024
11:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form EFFECT | |
12/20/2024
7:00 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/17/2024
3:30 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/06/2024
4:25 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
3:00 PM | Parikh Sanam (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/21/2024
3:51 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:06 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for HILS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Hillstream BioPharma and its competitors with MarketBeat's FREE daily newsletter. |
11/07/2024
4:22 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
3:15 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
8:58 AM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4/A | |
10/08/2024
3:10 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
9:00 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
8:06 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:17 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:17 PM | Bui Lynne A. (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:18 PM | Mazur Leonard L (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:18 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:18 PM | Anderson Kelly (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
2:09 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/23/2024
3:13 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 424B3 | |
07/21/2024
11:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form EFFECT | |
07/15/2024
3:43 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/28/2024
4:25 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/20/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
3:14 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/07/2024
4:21 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 424B5 | |
06/07/2024
4:23 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:30 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024
10:12 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEFA14A | |
03/22/2024
10:08 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form ARS | |
03/21/2024
4:25 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEF 14A | |
03/21/2024
4:27 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEFA14A | |
